A 5-carbon keto sugar.
Pentosephosphates are monosaccharides, specifically pentoses, that have a phosphate group attached, playing crucial roles in carbohydrate metabolism, such as being intermediates in the pentose phosphate pathway and serving as precursors for nucleotide synthesis.
Xylose is a monosaccharide, a type of sugar, that is commonly found in woody plants and fruits, and it is used in medical testing to assess the absorptive capacity of the small intestine.
Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia.
A five-carbon sugar alcohol derived from XYLOSE by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener.
A class of carbohydrates that contains five carbon atoms.
Enzymes that catalyze the interconversion of aldose and ketose compounds.
An enzyme that plays a role in the PENTOSES and GLUCURONATES interconversion pathway by catalyzing the oxidation of XYLITOL to D-xylulose. This enzyme has been found to be specific for NAD+.
An enzyme of the transferase class that catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate in the PENTOSE PHOSPHATE PATHWAY. (Dorland, 27th ed) EC 2.2.1.1.
Oxidoreductases that are specific for the reduction of NITRATES.
Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID.
Fructosephosphates are organic compounds resulting from the combination of fructose with a phosphate group, playing crucial roles in various metabolic processes, particularly within carbohydrate metabolism.
Ribonucleotide Reductases are enzymes that catalyze the conversion of ribonucleotides to deoxyribonucleotides, which is a crucial step in DNA synthesis and repair, utilizing a radical mechanism for this conversion.
Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3.
An oxidative decarboxylation process that converts GLUCOSE-6-PHOSPHATE to D-ribose-5-phosphate via 6-phosphogluconate. The pentose product is used in the biosynthesis of NUCLEIC ACIDS. The generated energy is stored in the form of NADPH. This pathway is prominent in tissues which are active in the synthesis of FATTY ACIDS and STEROIDS.
A FLAVOPROTEIN oxidoreductase that occurs both as a soluble enzyme and a membrane-bound enzyme due to ALTERNATIVE SPLICING of a single mRNA. The soluble form is present mainly in ERYTHROCYTES and is involved in the reduction of METHEMOGLOBIN. The membrane-bound form of the enzyme is found primarily in the ENDOPLASMIC RETICULUM and outer mitochondrial membrane, where it participates in the desaturation of FATTY ACIDS; CHOLESTEROL biosynthesis and drug metabolism. A deficiency in the enzyme can result in METHEMOGLOBINEMIA.
A group of enzymes that oxidize diverse nitrogenous substances to yield nitrite. (Enzyme Nomenclature, 1992) EC 1.
Hexosephosphates are sugar phosphate molecules, specifically those derived from hexoses (six-carbon sugars), such as glucose-6-phosphate and fructose-6-phosphate, which play crucial roles in various metabolic pathways including glycolysis, gluconeogenesis, and the pentose phosphate pathway.
Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2.
An enzyme that utilizes NADH or NADPH to reduce FLAVINS. It is involved in a number of biological processes that require reduced flavin for their functions such as bacterial bioluminescence. Formerly listed as EC 1.6.8.1 and EC 1.5.1.29.
A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXINS to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5
A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. EC 1.6.2.4.
An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.
The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9)
Cytochrome reductases are enzymes that catalyze the transfer of electrons from donor molecules to cytochromes in electron transport chains, playing a crucial role in cellular respiration and energy production within cells.
A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (Dorland, 27th ed) EC 1.5.1.3.
A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This enzyme was formerly classified as EC 1.1.1.171.
An NAD-dependent enzyme that catalyzes the oxidation of nitrite to nitrate. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM and is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. It was formerly classified as EC 1.6.6.1.
Reductases that catalyze the reaction of peptide-L-methionine -S-oxide + thioredoxin to produce peptide-L-methionine + thioredoxin disulfide + H(2)O.
Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed)
An enzyme of the oxidoreductase class that catalyzes the formation of 2'-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. (From Dorland, 27th ed) EC 1.17.4.1.
Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.
NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE);) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol.
A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99).
A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6.
A subclass of enzymes which includes all dehydrogenases acting on carbon-carbon bonds. This enzyme group includes all the enzymes that introduce double bonds into substrates by direct dehydrogenation of carbon-carbon single bonds.
An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7.
A subtype of thioredoxin reductase found primarily in the CYTOSOL.
An NAD-dependent enzyme that catalyzes the oxidation of acyl-[acyl-carrier protein] to trans-2,3-dehydroacyl-[acyl-carrier protein]. It has a preference for acyl groups with a carbon chain length between 4 to 16.
A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471).
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The rate dynamics in chemical or physical systems.
Oxidoreductases with specificity for oxidation or reduction of SULFUR COMPOUNDS.
Mevalonic acid is a crucial intermediate compound in the HMG-CoA reductase pathway, which is a metabolic route that produces cholesterol, other steroids, and isoprenoids in cells.
A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.
A 3-oxoacyl reductase that has specificity for ACYL CARRIER PROTEIN-derived FATTY ACIDS.
Oxidoreductases that specifically reduce arsenate ion to arsenite ion. Reduction of arsenate is a critical step for its biotransformation into a form that can be transported by ARSENITE TRANSPORTING ATPASES or complexed by specific sulfhydryl-containing proteins for the purpose of detoxification (METABOLIC DETOXIFICATION, DRUG). Arsenate reductases require reducing equivalents such as GLUTAREDOXIN or AZURIN.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE along with molybdoferredoxin and is active in nitrogen fixation.
Reversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99.
A NADPH-dependent oxidase that reduces hydrogen sulfite to HYDROGEN SULFIDE. It is found in many microoganisms.
A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972)
An enzyme found primarily in SULFUR-REDUCING BACTERIA where it plays an important role in the anaerobic carbon oxidation pathway.
Specific hydroxymethylglutaryl CoA reductases that utilize the cofactor NAD. In liver enzymes of this class are involved in cholesterol biosynthesis.
An enzyme that catalyzes the oxidation of D-glycerate to hydroxypyruvate in the presence of NADP.
Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)
Hydrogen-donating proteins that participates in a variety of biochemical reactions including ribonucleotide reduction and reduction of PEROXIREDOXINS. Thioredoxin is oxidized from a dithiol to a disulfide when acting as a reducing cofactor. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE.
An FAD-dependent oxidoreductase found primarily in BACTERIA. It is specific for the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This enzyme was formerly listed as EC 1.1.1.68 and 1.1.99.15.
A subtype of thioredoxin reductase found primarily in MITOCHONDRIA.
An iron-sulfur and MOLYBDENUM containing FLAVOPROTEIN that catalyzes the oxidation of nitrite to nitrate. This enzyme can use either NAD or NADP as cofactors. It is a key enzyme that is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. This enzyme was formerly classified as EC 1.6.6.2.
A group of enzymes that catalyze the reduction of 1-pyrroline carboxylate to proline in the presence of NAD(P)H. Includes both the 2-oxidoreductase (EC 1.5.1.1) and the 5-oxidoreductase (EC 1.5.1.2). The former also reduces 1-piperidine-2-carboxylate to pipecolate and the latter also reduces 1-pyrroline-3-hydroxy-5-carboxylate to hydroxyproline.

Evidence that the gene YLR070c of Saccharomyces cerevisiae encodes a xylitol dehydrogenase. (1/40)

The open reading frame YLR070c of Saccharomyces cerevisiae has high sequence similarity to S. cerevisiae sorbitol dehydrogenase and to xylitol dehydrogenase of Pichia stipitis. Overexpression of this open reading frame in S. cerevisiae resulted in xylitol dehydrogenase activity. The enzyme is specific for NADH. The following Michaelis constants were estimated: D-xylulose, 1.1 mM; NADH, 240 microM (at pH 7.0); xylitol, 25 mM; NAD, 100 microM (at pH 9.0). Xylitol dehydrogenase activity with the same kinetic properties can also be induced by xylose in wild type S. cerevisiae cells.  (+info)

Xylulokinase overexpression in two strains of Saccharomyces cerevisiae also expressing xylose reductase and xylitol dehydrogenase and its effect on fermentation of xylose and lignocellulosic hydrolysate. (2/40)

Fermentation of the pentose sugar xylose to ethanol in lignocellulosic biomass would make bioethanol production economically more competitive. Saccharomyces cerevisiae, an efficient ethanol producer, can utilize xylose only when expressing the heterologous genes XYL1 (xylose reductase) and XYL2 (xylitol dehydrogenase). Xylose reductase and xylitol dehydrogenase convert xylose to its isomer xylulose. The gene XKS1 encodes the xylulose-phosphorylating enzyme xylulokinase. In this study, we determined the effect of XKS1 overexpression on two different S. cerevisiae host strains, H158 and CEN.PK, also expressing XYL1 and XYL2. H158 has been previously used as a host strain for the construction of recombinant xylose-utilizing S. cerevisiae strains. CEN.PK is a new strain specifically developed to serve as a host strain for the development of metabolic engineering strategies. Fermentation was carried out in defined and complex media containing a hexose and pentose sugar mixture or a birch wood lignocellulosic hydrolysate. XKS1 overexpression increased the ethanol yield by a factor of 2 and reduced the xylitol yield by 70 to 100% and the final acetate concentrations by 50 to 100%. However, XKS1 overexpression reduced the total xylose consumption by half for CEN.PK and to as little as one-fifth for H158. Yeast extract and peptone partly restored sugar consumption in hydrolysate medium. CEN.PK consumed more xylose but produced more xylitol than H158 and thus gave lower ethanol yields on consumed xylose. The results demonstrate that strain background and modulation of XKS1 expression are important for generating an efficient xylose-fermenting recombinant strain of S. cerevisiae.  (+info)

Novel enzymatic method for the production of xylitol from D-arabitol by Gluconobacter oxydans. (3/40)

Microorganisms capable of producing xylitol from D-arabitol were screened for. Of the 420 strains tested, three bacteria, belonging to the genera Acetobacter and Gluconobacter, produced xylitol from D-arabitol when intact cells were used as the enzyme source. Among them, Gluconobacter oxydans ATCC 621 produced 29.2 g/l xylitol from 52.4 g/l D-arabitol after incubation for 27 h. The production of xylitol was increased by the addition of 5% (v/v) ethanol and 5 g/l D-glucose to the reaction mixture. Under these conditions, 51.4 g/l xylitol was obtained from 52.4 g/l D-arabitol, a yield of 98%, after incubation for 27 h. This conversion consisted of two successive reactions, conversion of D-arabitol to D-xylulose by a membrane-bound D-arabitol dehydrogenase, and conversion of D-xylulose to xylitol by a soluble NAD-dependent xylitol dehydrogenase. Use of disruptants of the membrane-bound alcohol dehydrogenase genes suggested that NADH was generated via NAD-dependent soluble alcohol dehydrogenase.  (+info)

Evolutionary engineering of Saccharomyces cerevisiae for anaerobic growth on xylose. (4/40)

Xylose utilization is of commercial interest for efficient conversion of abundant plant material to ethanol. Perhaps the most important ethanol-producing organism, Saccharomyces cerevisiae, however, is incapable of xylose utilization. While S. cerevisiae strains have been metabolically engineered to utilize xylose, none of the recombinant strains or any other naturally occurring yeast has been able to grow anaerobically on xylose. Starting with the recombinant S. cerevisiae strain TMB3001 that overexpresses the xylose utilization pathway from Pichia stipitis, in this study we developed a selection procedure for the evolution of strains that are capable of anaerobic growth on xylose alone. Selection was successful only when organisms were first selected for efficient aerobic growth on xylose alone and then slowly adapted to microaerobic conditions and finally anaerobic conditions, which indicated that multiple mutations were necessary. After a total of 460 generations or 266 days of selection, the culture reproduced stably under anaerobic conditions on xylose and consisted primarily of two subpopulations with distinct phenotypes. Clones in the larger subpopulation grew anaerobically on xylose and utilized both xylose and glucose simultaneously in batch culture, but they exhibited impaired growth on glucose. Surprisingly, clones in the smaller subpopulation were incapable of anaerobic growth on xylose. However, as a consequence of their improved xylose catabolism, these clones produced up to 19% more ethanol than the parental TMB3001 strain produced under process-like conditions from a mixture of glucose and xylose.  (+info)

Cloning of the xylitol dehydrogenase gene from Gluconobacter oxydans and improved production of xylitol from D-arabitol. (5/40)

Xylitol dehydrogenase (XDH) was purified from the cytoplasmic fraction of Gluconobacter oxydans ATCC 621. The purified enzyme reduced D-xylulose to xylitol in the presence of NADH with an optimum pH of around 5.0. Based on the determined NH2-terminal amino acid sequence, the gene encoding xdh was cloned, and its identity was confirmed by expression in Escherichia coli. The xdh gene encodes a polypeptide composed of 262 amino acid residues, with an estimated molecular mass of 27.8 kDa. The deduced amino acid sequence suggested that the enzyme belongs to the short-chain dehydrogenase/reductase family. Expression plasmids for the xdh gene were constructed and used to produce recombinant strains of G. oxydans that had up to 11-fold greater XDH activity than the wild-type strain. When used in the production of xylitol from D-arabitol under controlled aeration and pH conditions, the strain harboring the xdh expression plasmids produced 57 g/l xylitol from 225 g/l D-arabitol, whereas the control strain produced 27 g/l xylitol. These results demonstrated that increasing XDH activity in G. oxydans improved xylitol productivity.  (+info)

D-xylose metabolism in Hypocrea jecorina: loss of the xylitol dehydrogenase step can be partially compensated for by lad1-encoded L-arabinitol-4-dehydrogenase. (6/40)

With the goal of the genetic characterization of the D-xylose pathway in Hypocrea jecorina (anamorph: Trichoderma reesei), we cloned the xdh1 gene, encoding NAD-xylitol dehydrogenase, which catalyzes the second step of fungal D-xylose catabolism. This gene encodes a 363-amino-acid protein which has a mass of 38 kDa, belongs to the zinc-containing alcohol dehydrogenase family, exhibits high sequence identity to the published sequences of xylitol dehydrogenases from yeast origins, but contains a second, additional binding site for Zn2+. The enzyme catalyzed the NAD-dependent oxidation of xylitol and D-sorbitol and the NADH-dependent reduction of D-xylulose and D-fructose. No activity was observed with NADP, L-arabinose, or L-arabinitol. A single 1.4-kb transcript was formed during growth on xylan, D-xylose, L-arabinose, L-arabinitol and, at a lower abundance, xylitol, D-galactose, galactitol, and lactose but not on D-glucose and glycerol. xdh1 deletion mutants exhibited 50% reduced growth rates on D-xylose, whereas growth rates on xylitol remained unaltered. These mutants contained 30% of the xylitol dehydrogenase activity of the parent strain, indicating the presence of a second xylitol dehydrogenase. This activity was shown to be due to lad1-encoded L-arabinitol-4-dehydrogenase, because H. jecorina xdh1 lad1 double-deletion strains failed to grow on D-xylose or xylitol. In contrast, lad1 deletion strains of H. jecorina grew normally on these carbon sources. These results show that H. jecorina contains a single xylitol dehydrogenase which is encoded by xdh1 and is involved in the metabolism of D-xylose and that lad1-encoded L-arabinitol-4-dehydrogenase can compensate for it partially in mutants with a loss of xdh1 function.  (+info)

Endogenous xylose pathway in Saccharomyces cerevisiae. (7/40)

The baker's yeast Saccharomyces cerevisiae is generally classified as a non-xylose-utilizing organism. We found that S. cerevisiae can grow on D-xylose when only the endogenous genes GRE3 (YHR104w), coding for a nonspecific aldose reductase, and XYL2 (YLR070c, ScXYL2), coding for a xylitol dehydrogenase (XDH), are overexpressed under endogenous promoters. In nontransformed S. cerevisiae strains, XDH activity was significantly higher in the presence of xylose, but xylose reductase (XR) activity was not affected by the choice of carbon source. The expression of SOR1, encoding a sorbitol dehydrogenase, was elevated in the presence of xylose as were the genes encoding transketolase and transaldolase. An S. cerevisiae strain carrying the XR and XDH enzymes from the xylose-utilizing yeast Pichia stipitis grew more quickly and accumulated less xylitol than did the strain overexpressing the endogenous enzymes. Overexpression of the GRE3 and ScXYL2 genes in the S. cerevisiae CEN.PK2 strain resulted in a growth rate of 0.01 g of cell dry mass liter(-1) h(-1) and a xylitol yield of 55% when xylose was the main carbon source.  (+info)

Complete reversal of coenzyme specificity of xylitol dehydrogenase and increase of thermostability by the introduction of structural zinc. (8/40)

Pichia stipitis NAD(+)-dependent xylitol dehydrogenase (XDH), a medium-chain dehydrogenase/reductase, is one of the key enzymes in ethanol fermentation from xylose. For the construction of an efficient biomass-ethanol conversion system, we focused on the two areas of XDH, 1) change of coenzyme specificity from NAD(+) to NADP(+) and 2) thermostabilization by introducing an additional zinc atom. Site-directed mutagenesis was used to examine the roles of Asp(207), Ile(208), Phe(209), and Asn(211) in the discrimination between NAD(+) and NADP(+). Single mutants (D207A, I208R, F209S, and N211R) improved 5 approximately 48-fold in catalytic efficiency (k(cat)/K(m)) with NADP(+) compared with the wild type but retained substantial activity with NAD(+). The double mutants (D207A/I208R and D207A/F209S) improved by 3 orders of magnitude in k(cat)/K(m) with NADP(+), but they still preferred NAD(+) to NADP(+). The triple mutant (D207A/I208R/F209S) and quadruple mutant (D207A/I208R/F209S/N211R) showed more than 4500-fold higher values in k(cat)/K(m) with NADP(+) than the wild-type enzyme, reaching values comparable with k(cat)/K(m) with NAD(+) of the wild-type enzyme. Because most NADP(+)-dependent XDH mutants constructed in this study decreased the thermostability compared with the wild-type enzyme, we attempted to improve the thermostability of XDH mutants by the introduction of an additional zinc atom. The introduction of three cysteine residues in wild-type XDH gave an additional zinc-binding site and improved the thermostability. The introduction of this mutation in D207A/I208R/F209S and D207A/I208R/F209S/N211R mutants increased the thermostability and further increased the catalytic activity with NADP(+).  (+info)

Xylulose is a ketopentose, which is a type of sugar (monosaccharide) with five carbon atoms and a ketone functional group. It is a less common sugar compared to glucose or fructose. Xylulose can be found in small amounts in some fruits and vegetables, and it can also be produced in the human body during the metabolism of certain substances like xylitol, a sugar alcohol used as a sweetener. In the body, xylulose is converted into xylulose-5-phosphate, which plays a role in the pentose phosphate pathway, a metabolic route that generates reducing power (NADPH) for biosynthesis and provides precursors for nucleotide synthesis.

Pentose phosphates are monosaccharides that contain five carbon atoms and one phosphate group. They play a crucial role in various metabolic pathways, including the pentose phosphate pathway (PPP), which is a major source of NADPH and ribose-5-phosphate for the synthesis of nucleotides.

The pentose phosphate pathway involves two main phases: the oxidative phase and the non-oxidative phase. In the oxidative phase, glucose-6-phosphate is converted to ribulose-5-phosphate, producing NADPH and CO2 as byproducts. Ribulose-5-phosphate can then be further metabolized in the non-oxidative phase to produce other pentose phosphates or converted back to glucose-6-phosphate through a series of reactions.

Pentose phosphates are also important intermediates in the synthesis of nucleotides, coenzymes, and other metabolites. Abnormalities in pentose phosphate pathway enzymes can lead to various metabolic disorders, such as defects in erythrocyte function and increased susceptibility to oxidative stress.

Xylose is a type of sugar that is commonly found in plants and wood. In the context of medical definitions, xylose is often used in tests to assess the function of the small intestine. The most common test is called the "xylose absorption test," which measures the ability of the small intestine to absorb this sugar.

In this test, a patient is given a small amount of xylose to drink, and then several blood and/or urine samples are collected over the next few hours. The amount of xylose that appears in these samples is measured and used to determine how well the small intestine is absorbing nutrients.

Abnormal results on a xylose absorption test can indicate various gastrointestinal disorders, such as malabsorption syndromes, celiac disease, or bacterial overgrowth in the small intestine.

Liver extracts are preparations made from animal livers, often from cows or pigs, that contain various nutrients, vitamins, and minerals found in liver tissue. They have been used historically in medicine as a source of nutrition and to treat certain medical conditions.

Liver extracts contain high levels of vitamin B12, iron, and other essential nutrients. They were once commonly prescribed to treat anemia, pernicious anemia (a type of anemia caused by vitamin B12 deficiency), and other conditions related to malnutrition. However, with the advent of more modern treatments and better methods for addressing nutritional deficiencies, liver extracts are less commonly used in modern medicine.

It's important to note that while liver extracts can be a good source of nutrition, they should not be used as a substitute for a balanced diet. Moreover, individuals with certain medical conditions, such as liver disease or hemochromatosis (a condition characterized by excessive iron absorption), should avoid liver extracts or use them only under the supervision of a healthcare provider.

Xylitol is a type of sugar alcohol used as a sugar substitute in various food and dental products. It has a sweet taste similar to sugar but with fewer calories and less impact on blood sugar levels, making it a popular choice for people with diabetes or those looking to reduce their sugar intake. Xylitol is also known to have dental benefits, as it can help prevent tooth decay by reducing the amount of bacteria in the mouth that cause cavities.

Medically speaking, xylitol is classified as a carbohydrate and has a chemical formula of C5H12O5. It occurs naturally in some fruits and vegetables, but most commercial xylitol is produced from corn cobs or other plant materials through a process called hydrogenation. While generally considered safe for human consumption, it can have a laxative effect in large amounts and may be harmful to dogs, so it's important to keep it out of reach of pets.

A pentose is a monosaccharide (simple sugar) that contains five carbon atoms. The name "pentose" comes from the Greek word "pente," meaning five, and "ose," meaning sugar. Pentoses play important roles in various biological processes, such as serving as building blocks for nucleic acids (DNA and RNA) and other biomolecules.

Some common pentoses include:

1. D-Ribose - A naturally occurring pentose found in ribonucleic acid (RNA), certain coenzymes, and energy-carrying molecules like adenosine triphosphate (ATP).
2. D-Deoxyribose - A pentose that lacks a hydroxyl (-OH) group on the 2' carbon atom, making it a key component of deoxyribonucleic acid (DNA).
3. Xylose - A naturally occurring pentose found in various plants and woody materials; it is used as a sweetener and food additive.
4. Arabinose - Another plant-derived pentose, arabinose can be found in various fruits, vegetables, and grains. It has potential applications in the production of biofuels and other bioproducts.
5. Lyxose - A less common pentose that can be found in some polysaccharides and glycoproteins.

Pentoses are typically less sweet than hexoses (six-carbon sugars) like glucose or fructose, but they still contribute to the overall sweetness of many foods and beverages.

Aldose-ketose isomerases are a group of enzymes that catalyze the interconversion between aldoses and ketoses, which are different forms of sugars. These enzymes play an essential role in carbohydrate metabolism by facilitating the reversible conversion of aldoses to ketoses and vice versa.

Aldoses are sugars that contain a carbonyl group (a functional group consisting of a carbon atom double-bonded to an oxygen atom) at the end of the carbon chain, while ketoses have their carbonyl group located in the middle of the chain. The isomerization process catalyzed by aldose-ketose isomerases helps maintain the balance between these two forms of sugars and enables cells to utilize them more efficiently for energy production and other metabolic processes.

There are several types of aldose-ketose isomerases, including:

1. Triose phosphate isomerase (TPI): This enzyme catalyzes the interconversion between dihydroxyacetone phosphate (a ketose) and D-glyceraldehyde 3-phosphate (an aldose), which are both trioses (three-carbon sugars). TPI plays a crucial role in glycolysis, the metabolic pathway that breaks down glucose to produce energy.
2. Xylulose kinase: This enzyme is involved in the pentose phosphate pathway, which is a metabolic route that generates reducing equivalents (NADPH) and pentoses for nucleic acid synthesis. Xylulose kinase catalyzes the conversion of D-xylulose (a ketose) to D-xylulose 5-phosphate, an important intermediate in the pentose phosphate pathway.
3. Ribulose-5-phosphate 3-epimerase: This enzyme is also part of the pentose phosphate pathway and catalyzes the interconversion between D-ribulose 5-phosphate (an aldose) and D-xylulose 5-phosphate (a ketose).
4. Phosphoglucomutase: This enzyme catalyzes the reversible conversion of glucose 1-phosphate (an aldose) to glucose 6-phosphate (an aldose), which is an important intermediate in both glycolysis and gluconeogenesis.
5. Phosphomannomutase: This enzyme catalyzes the reversible conversion of mannose 1-phosphate (a ketose) to mannose 6-phosphate (an aldose), which is involved in the biosynthesis of complex carbohydrates.

These are just a few examples of enzymes that catalyze the interconversion between aldoses and ketoses, highlighting their importance in various metabolic pathways.

D-Xylulose Reductase is an enzyme that catalyzes the reduction of D-xylulose to xylitol using NADPH as a cofactor. This enzyme plays a role in the pentose phosphate pathway, which is a metabolic pathway that supplies reducing energy to cells by maintaining the level of the coenzyme NADPH. D-Xylulose Reductase is also involved in the metabolism of xylose, a type of sugar found in some fruits and vegetables, and is therefore of interest in the development of processes for the conversion of xylose to xylitol, a sweetener used in various food and pharmaceutical applications.

Transketolase is an enzyme found in most organisms, from bacteria to humans. It plays a crucial role in the pentose phosphate pathway (PPP), which is a metabolic pathway that runs alongside glycolysis in the cell cytoplasm. The PPP provides an alternative way of generating energy and also serves to provide building blocks for new cellular components, particularly nucleotides.

Transketolase functions by catalyzing the transfer of a two-carbon ketol group from a ketose (a sugar containing a ketone functional group) to an aldose (a sugar containing an aldehyde functional group). This reaction forms a new ketose and an aldose, effectively converting three-carbon sugars into five-carbon sugars, or vice versa.

In humans, transketolase is essential for the production of NADPH, an important reducing agent in the cell, and for the synthesis of certain amino acids and nucleotides. Deficiencies in this enzyme can lead to metabolic disorders such as pentosuria.

Nitrate reductases are a group of enzymes that catalyze the reduction of nitrate (NO3-) to nitrite (NO2-). This process is an essential part of the nitrogen cycle, where nitrate serves as a terminal electron acceptor in anaerobic respiration for many bacteria and archaea. In plants, this enzyme plays a crucial role in nitrogen assimilation by reducing nitrate to ammonium (NH4+), which can then be incorporated into organic compounds. Nitrate reductases require various cofactors, such as molybdenum, heme, and/or FAD, for their activity. There are three main types of nitrate reductases: membrane-bound (which use menaquinol as an electron donor), cytoplasmic (which use NADH or NADPH as an electron donor), and assimilatory (which also use NADH or NADPH as an electron donor).

Hydroxymethylglutaryl CoA (HMG-CoA) reductase is an enzyme that plays a crucial role in the synthesis of cholesterol in the body. It is found in the endoplasmic reticulum of cells and catalyzes the conversion of HMG-CoA to mevalonic acid, which is a key rate-limiting step in the cholesterol biosynthetic pathway.

The reaction catalyzed by HMG-CoA reductase is as follows:

HMG-CoA + 2 NADPH + 2 H+ → mevalonic acid + CoA + 2 NADP+

This enzyme is the target of statin drugs, which are commonly prescribed to lower cholesterol levels in the treatment of cardiovascular diseases. Statins work by inhibiting HMG-CoA reductase, thereby reducing the production of cholesterol in the body.

Fructose-1,6-bisphosphate (also known as fructose 1,6-diphosphate or Fru-1,6-BP) is the chemical compound that plays a crucial role in cellular respiration and glucose metabolism. It is not accurate to refer to "fructosephosphates" as a medical term, but fructose-1-phosphate and fructose-1,6-bisphosphate are important fructose phosphates with specific functions in the body.

Fructose-1-phosphate is an intermediate metabolite formed during the breakdown of fructose in the liver, while fructose-1,6-bisphosphate is a key regulator of glycolysis, the process by which glucose is broken down to produce energy in the form of ATP. Fructose-1,6-bisphosphate allosterically regulates the enzyme phosphofructokinase, which is the rate-limiting step in glycolysis, and its levels are tightly controlled to maintain proper glucose metabolism. Dysregulation of fructose metabolism has been implicated in various metabolic disorders, including insulin resistance, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD).

Ribonucleotide Reductases (RNRs) are enzymes that play a crucial role in DNA synthesis and repair. They catalyze the conversion of ribonucleotides to deoxyribonucleotides, which are the building blocks of DNA. This process involves the reduction of the 2'-hydroxyl group of the ribose sugar to a hydrogen, resulting in the formation of deoxyribose.

RNRs are highly regulated and exist in various forms across different species. They are divided into three classes (I, II, and III) based on their structure, mechanism, and cofactor requirements. Class I RNRs are further divided into two subclasses (Ia and Ib), which differ in their active site architecture and regulation.

Class Ia RNRs, found in eukaryotes and some bacteria, contain a stable tyrosyl radical that acts as the catalytic center for hydrogen abstraction. Class Ib RNRs, found in many bacteria, use a pair of iron centers to perform the same function. Class II RNRs are present in some bacteria and archaea and utilize adenosine triphosphate (ATP) as a cofactor for reduction. Class III RNRs, found in anaerobic bacteria and archaea, use a unique mechanism involving a radical S-adenosylmethionine (SAM) cofactor to facilitate the reduction reaction.

RNRs are essential for DNA replication and repair, and their dysregulation has been linked to various diseases, including cancer and neurodegenerative disorders. Therefore, understanding the structure, function, and regulation of RNRs is of great interest in biochemistry, molecular biology, and medicine.

Carbohydrate epimerases are a group of enzymes that catalyze the interconversion of specific stereoisomers (epimers) of carbohydrates by the reversible oxidation and reduction of carbon atoms, usually at the fourth or fifth position. These enzymes play important roles in the biosynthesis and modification of various carbohydrate-containing molecules, such as glycoproteins, proteoglycans, and glycolipids, which are involved in numerous biological processes including cell recognition, signaling, and adhesion.

The reaction catalyzed by carbohydrate epimerases involves the transfer of a hydrogen atom and a proton between two adjacent carbon atoms, leading to the formation of new stereochemical configurations at these positions. This process can result in the conversion of one epimer into another, thereby expanding the structural diversity of carbohydrates and their derivatives.

Carbohydrate epimerases are classified based on the type of substrate they act upon and the specific stereochemical changes they induce. Some examples include UDP-glucose 4-epimerase, which interconverts UDP-glucose and UDP-galactose; UDP-N-acetylglucosamine 2-epimerase, which converts UDP-N-acetylglucosamine to UDP-N-acetylmannosamine; and GDP-fucose synthase, which catalyzes the conversion of GDP-mannose to GDP-fucose.

Understanding the function and regulation of carbohydrate epimerases is crucial for elucidating their roles in various biological processes and developing strategies for targeting them in therapeutic interventions.

The Pentose Phosphate Pathway (also known as the Hexose Monophosphate Shunt or HMP Shunt) is a metabolic pathway that runs parallel to glycolysis. It serves two major functions:

1. Providing reducing equivalents in the form of NADPH for reductive biosynthesis and detoxification processes.
2. Generating ribose-5-phosphate, a pentose sugar used in the synthesis of nucleotides and nucleic acids (DNA and RNA).

This pathway begins with the oxidation of glucose-6-phosphate to form 6-phosphogluconolactone, catalyzed by the enzyme glucose-6-phosphate dehydrogenase. The resulting NADPH is used in various anabolic reactions and antioxidant defense systems.

The Pentose Phosphate Pathway also includes a series of reactions called the non-oxidative branch, which interconverts various sugars to meet cellular needs for different types of monosaccharides. These conversions are facilitated by several enzymes including transketolase and transaldolase.

Nitrite reductases are a group of enzymes that catalyze the reduction of nitrite (NO2-) to nitric oxide (NO). This reaction is an important part of the nitrogen cycle, particularly in denitrification and dissimilatory nitrate reduction to ammonium (DNRA) processes. Nitrite reductases can be classified into two main types based on their metal co-factors: copper-containing nitrite reductases (CuNiRs) and cytochrome cd1 nitrite reductases. CuNiRs are typically found in bacteria and fungi, while cytochrome cd1 nitrite reductases are primarily found in bacteria. These enzymes play a crucial role in the global nitrogen cycle and have potential implications for environmental and medical research.

Hexose phosphates are organic compounds that consist of a hexose sugar molecule (a monosaccharide containing six carbon atoms, such as glucose or fructose) that has been phosphorylated, meaning that a phosphate group has been added to it. This process is typically facilitated by enzymes called kinases, which transfer a phosphate group from a donor molecule (usually ATP) to the sugar molecule.

Hexose phosphates play important roles in various metabolic pathways, including glycolysis, gluconeogenesis, and the pentose phosphate pathway. For example, glucose-6-phosphate is a key intermediate in both glycolysis and gluconeogenesis, while fructose-6-phosphate and fructose-1,6-bisphosphate are important intermediates in glycolysis. The pentose phosphate pathway, which is involved in the production of NADPH and ribose-5-phosphate, begins with the conversion of glucose-6-phosphate to 6-phosphogluconolactone by the enzyme glucose-6-phosphate dehydrogenase.

Overall, hexose phosphates are important metabolic intermediates that help regulate energy production and utilization in cells.

Glutathione reductase (GR) is an enzyme that plays a crucial role in maintaining the cellular redox state. The primary function of GR is to reduce oxidized glutathione (GSSG) to its reduced form (GSH), which is an essential intracellular antioxidant. This enzyme utilizes nicotinamide adenine dinucleotide phosphate (NADPH) as a reducing agent in the reaction, converting it to NADP+. The medical definition of Glutathione Reductase is:

Glutathione reductase (GSR; EC 1.8.1.7) is a homodimeric flavoprotein that catalyzes the reduction of oxidized glutathione (GSSG) to reduced glutathione (GSH) in the presence of NADPH as a cofactor. This enzyme is essential for maintaining the cellular redox balance and protecting cells from oxidative stress by regenerating the active form of glutathione, a vital antioxidant and detoxifying agent.

Flavin Mononucleotide (FMN) Reductase is an enzyme that catalyzes the reduction of FMN to FMNH2 using NADH or NADPH as an electron donor. This enzyme plays a crucial role in the electron transport chain and is involved in various redox reactions within the cell. It is found in many organisms, including bacteria, fungi, plants, and animals. In humans, FMN Reductase is encoded by the RIBFLR gene and is primarily located in the mitochondria. Defects in this enzyme can lead to various metabolic disorders.

Thioredoxin-disulfide reductase (Txnrd, TrxR) is an enzyme that belongs to the pyridine nucleotide-disulfide oxidoreductase family. It plays a crucial role in maintaining the intracellular redox balance by reducing disulfide bonds in proteins and keeping them in their reduced state. This enzyme utilizes NADPH as an electron donor to reduce thioredoxin (Trx), which then transfers its electrons to various target proteins, thereby regulating their activity, protein folding, and antioxidant defense mechanisms.

Txnrd is essential for several cellular processes, including DNA synthesis, gene expression, signal transduction, and protection against oxidative stress. Dysregulation of Txnrd has been implicated in various pathological conditions, such as cancer, neurodegenerative diseases, and inflammatory disorders. Therefore, understanding the function and regulation of this enzyme is of great interest for developing novel therapeutic strategies.

NADPH-ferrihemoprotein reductase, also known as diaphorase or NO synthase reductase, is an enzyme that catalyzes the reduction of ferrihemoproteins using NADPH as a reducing cofactor. This reaction plays a crucial role in various biological processes such as the detoxification of certain compounds and the regulation of cellular signaling pathways.

The systematic name for this enzyme is NADPH:ferrihemoprotein oxidoreductase, and it belongs to the family of oxidoreductases that use NADH or NADPH as electron donors. The reaction catalyzed by this enzyme can be represented as follows:

NADPH + H+ + ferrihemoprotein ↔ NADP+ + ferrohemoprotein

In this reaction, the ferric (FeIII) form of hemoproteins is reduced to its ferrous (FeII) form by accepting electrons from NADPH. This enzyme is widely distributed in various tissues and organisms, including bacteria, fungi, plants, and animals. It has been identified as a component of several multi-enzyme complexes involved in different metabolic pathways, such as nitric oxide synthase (NOS) and cytochrome P450 reductase.

In summary, NADPH-ferrihemoprotein reductase is an essential enzyme that catalyzes the reduction of ferrihemoproteins using NADPH as a reducing agent, playing a critical role in various biological processes and metabolic pathways.

Ferredoxin-NADP Reductase (FDNR) is an enzyme that catalyzes the electron transfer from ferredoxin to NADP+, reducing it to NADPH. This reaction plays a crucial role in several metabolic pathways, including photosynthesis and nitrogen fixation.

In photosynthesis, FDNR is located in the stroma of chloroplasts and receives electrons from ferredoxin, which is reduced by photosystem I. The enzyme then transfers these electrons to NADP+, generating NADPH, which is used in the Calvin cycle for carbon fixation.

In nitrogen fixation, FDNR is found in the nitrogen-fixing bacteria and receives electrons from ferredoxin, which is reduced by nitrogenase. The enzyme then transfers these electrons to NADP+, generating NADPH, which is used in the reduction of nitrogen gas (N2) to ammonia (NH3).

FDNR is a flavoprotein that contains a FAD cofactor and an iron-sulfur cluster. The enzyme catalyzes the electron transfer through a series of conformational changes that bring ferredoxin and NADP+ in close proximity, allowing for efficient electron transfer.

Oxidoreductases are a class of enzymes that catalyze oxidation-reduction reactions, which involve the transfer of electrons from one molecule (the reductant) to another (the oxidant). These enzymes play a crucial role in various biological processes, including energy production, metabolism, and detoxification.

The oxidoreductase-catalyzed reaction typically involves the donation of electrons from a reducing agent (donor) to an oxidizing agent (acceptor), often through the transfer of hydrogen atoms or hydride ions. The enzyme itself does not undergo any permanent chemical change during this process, but rather acts as a catalyst to lower the activation energy required for the reaction to occur.

Oxidoreductases are classified and named based on the type of electron donor or acceptor involved in the reaction. For example, oxidoreductases that act on the CH-OH group of donors are called dehydrogenases, while those that act on the aldehyde or ketone groups are called oxidases. Other examples include reductases, peroxidases, and catalases.

Understanding the function and regulation of oxidoreductases is important for understanding various physiological processes and developing therapeutic strategies for diseases associated with impaired redox homeostasis, such as cancer, neurodegenerative disorders, and cardiovascular disease.

Cytochrome reductases are a group of enzymes that play a crucial role in the electron transport chain, a process that occurs in the mitochondria of cells and is responsible for generating energy in the form of ATP (adenosine triphosphate). Specifically, cytochrome reductases are responsible for transferring electrons from one component of the electron transport chain to another, specifically to cytochromes.

There are several types of cytochrome reductases, including NADH dehydrogenase (also known as Complex I), succinate dehydrogenase (also known as Complex II), and ubiquinone-cytochrome c reductase (also known as Complex III). These enzymes help to facilitate the flow of electrons through the electron transport chain, which is essential for the production of ATP and the maintenance of cellular homeostasis.

Defects in cytochrome reductases can lead to a variety of mitochondrial diseases, which can affect multiple organ systems and may be associated with symptoms such as muscle weakness, developmental delays, and cardiac dysfunction.

Glucose is a simple monosaccharide (or single sugar) that serves as the primary source of energy for living organisms. It's a fundamental molecule in biology, often referred to as "dextrose" or "grape sugar." Glucose has the molecular formula C6H12O6 and is vital to the functioning of cells, especially those in the brain and nervous system.

In the body, glucose is derived from the digestion of carbohydrates in food, and it's transported around the body via the bloodstream to cells where it can be used for energy. Cells convert glucose into a usable form through a process called cellular respiration, which involves a series of metabolic reactions that generate adenosine triphosphate (ATP)—the main currency of energy in cells.

Glucose is also stored in the liver and muscles as glycogen, a polysaccharide (multiple sugar) that can be broken down back into glucose when needed for energy between meals or during physical activity. Maintaining appropriate blood glucose levels is crucial for overall health, and imbalances can lead to conditions such as diabetes mellitus.

Tetrahydrofolate dehydrogenase (EC 1.5.1.20) is an enzyme involved in folate metabolism. The enzyme catalyzes the oxidation of tetrahydrofolate (THF) to dihydrofolate (DHF), while simultaneously reducing NADP+ to NADPH.

The reaction can be summarized as follows:

THF + NADP+ -> DHF + NADPH + H+

This enzyme plays a crucial role in the synthesis of purines and thymidylate, which are essential components of DNA and RNA. Therefore, any defects or deficiencies in tetrahydrofolate dehydrogenase can lead to various medical conditions, including megaloblastic anemia and neural tube defects during fetal development.

Methionine sulfoxide reductases (MSRs) are a group of enzymes that catalyze the reduction of methionine sulfoxides back to methionine in proteins. Methionine residues in proteins can be oxidized by reactive oxygen species (ROS) or other oxidizing agents, leading to the formation of methionine sulfoxide. This modification can affect protein function and stability. MSRs play a crucial role in protecting proteins from oxidative damage and maintaining their proper function.

There are two types of MSRs, designated as MSRA and MSRB. MSRA reduces methionine-S-sulfoxides, while MSRB reduces methionine-R-sulfoxides. Both enzymes require the cofactor thioredoxin to reduce the methionine sulfoxide back to methionine. The activity of MSRs is important in various biological processes, including protein folding, stress response, and aging. Defects in MSRs have been implicated in several diseases, such as Alzheimer's disease, Parkinson's disease, and cancer.

NADP (Nicotinamide Adenine Dinucleotide Phosphate) is a coenzyme that plays a crucial role as an electron carrier in various redox reactions in the human body. It exists in two forms: NADP+, which functions as an oxidizing agent and accepts electrons, and NADPH, which serves as a reducing agent and donates electrons.

NADPH is particularly important in anabolic processes, such as lipid and nucleotide synthesis, where it provides the necessary reducing equivalents to drive these reactions forward. It also plays a critical role in maintaining the cellular redox balance by participating in antioxidant defense mechanisms that neutralize harmful reactive oxygen species (ROS).

In addition, NADP is involved in various metabolic pathways, including the pentose phosphate pathway and the Calvin cycle in photosynthesis. Overall, NADP and its reduced form, NADPH, are essential molecules for maintaining proper cellular function and energy homeostasis.

Ribonucleoside Diphosphate Reductase (RNR) is an enzyme that plays a crucial role in the regulation of DNA synthesis and repair. It catalyzes the conversion of ribonucleoside diphosphates (NDPs) to deoxyribonucleoside diphosphates (dNDPs), which are the building blocks of DNA. This reaction is essential for the synthesis of new DNA strands during replication and repair processes. The enzyme's activity is tightly regulated, as it must be carefully controlled to prevent errors in DNA synthesis that could lead to mutations and genomic instability. RNR is a target for chemotherapeutic agents due to its essential role in DNA synthesis.

Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors, also known as statins, are a class of cholesterol-lowering medications. They work by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. By blocking this enzyme, the liver is stimulated to take up more low-density lipoprotein (LDL) cholesterol from the bloodstream, leading to a decrease in LDL cholesterol levels and a reduced risk of cardiovascular disease.

Examples of HMG-CoA reductase inhibitors include atorvastatin, simvastatin, pravastatin, rosuvastatin, and fluvastatin. These medications are commonly prescribed to individuals with high cholesterol levels, particularly those who are at risk for or have established cardiovascular disease.

It's important to note that while HMG-CoA reductase inhibitors can be effective in reducing LDL cholesterol levels and the risk of cardiovascular events, they should be used as part of a comprehensive approach to managing high cholesterol, which may also include lifestyle modifications such as dietary changes, exercise, and weight management.

Quinone reductases are a group of enzymes that catalyze the reduction of quinones to hydroquinones, using NADH or NADPH as an electron donor. This reaction is important in the detoxification of quinones, which are potentially toxic compounds produced during the metabolism of certain drugs, chemicals, and endogenous substances.

There are two main types of quinone reductases: NQO1 (NAD(P)H:quinone oxidoreductase 1) and NQO2 (NAD(P)H:quinone oxidoreductase 2). NQO1 is a cytosolic enzyme that can reduce a wide range of quinones, while NQO2 is a mitochondrial enzyme with a narrower substrate specificity.

Quinone reductases have been studied for their potential role in cancer prevention and treatment, as they may help to protect cells from oxidative stress and DNA damage caused by quinones and other toxic compounds. Additionally, some quinone reductase inhibitors have been developed as chemotherapeutic agents, as they can enhance the cytotoxicity of certain drugs that require quinone reduction for activation.

Alcohol oxidoreductases are a class of enzymes that catalyze the oxidation of alcohols to aldehydes or ketones, while reducing nicotinamide adenine dinucleotide (NAD+) to NADH. These enzymes play an important role in the metabolism of alcohols and other organic compounds in living organisms.

The most well-known example of an alcohol oxidoreductase is alcohol dehydrogenase (ADH), which is responsible for the oxidation of ethanol to acetaldehyde in the liver during the metabolism of alcoholic beverages. Other examples include aldehyde dehydrogenases (ALDH) and sorbitol dehydrogenase (SDH).

These enzymes are important targets for the development of drugs used to treat alcohol use disorder, as inhibiting their activity can help to reduce the rate of ethanol metabolism and the severity of its effects on the body.

NADH, NADPH oxidoreductases are a class of enzymes that catalyze the redox reaction between NADH or NADPH and various electron acceptors. These enzymes play a crucial role in cellular metabolism by transferring electrons from NADH or NADPH to other molecules, which is essential for many biochemical reactions.

NADH (nicotinamide adenine dinucleotide hydrogen) and NADPH (nicotinamide adenine dinucleotide phosphate hydrogen) are coenzymes that act as electron carriers in redox reactions. They consist of a nicotinamide ring, which undergoes reduction or oxidation by accepting or donating electrons and a proton (H+).

NADH, NADPH oxidoreductases are classified based on their structure and mechanism of action. Some examples include:

1. Dehydrogenases: These enzymes catalyze the oxidation of NADH or NADPH to NAD+ or NADP+ while reducing an organic substrate. Examples include lactate dehydrogenase, alcohol dehydrogenase, and malate dehydrogenase.
2. Oxidases: These enzymes catalyze the oxidation of NADH or NADPH to NAD+ or NADP+ while reducing molecular oxygen (O2) to water (H2O). Examples include NADH oxidase and NADPH oxidase.
3. Reductases: These enzymes catalyze the reduction of various electron acceptors using NADH or NADPH as a source of electrons. Examples include glutathione reductase, thioredoxin reductase, and nitrate reductase.

Overall, NADH, NADPH oxidoreductases are essential for maintaining the redox balance in cells and play a critical role in various metabolic pathways, including energy production, detoxification, and biosynthesis.

Oxidoreductases acting on CH-CH group donors are a class of enzymes within the larger group of oxidoreductases, which are responsible for catalyzing oxidation-reduction reactions. Specifically, this subclass of enzymes acts upon donors containing a carbon-carbon (CH-CH) bond, where one atom or group of atoms is oxidized and another is reduced during the reaction process. These enzymes play crucial roles in various metabolic pathways, including the breakdown and synthesis of carbohydrates, lipids, and amino acids.

The reactions catalyzed by these enzymes involve the transfer of electrons and hydrogen atoms between the donor and an acceptor molecule. This process often results in the formation or cleavage of carbon-carbon bonds, making them essential for numerous biological processes. The systematic name for this class of enzymes is typically structured as "donor:acceptor oxidoreductase," where donor and acceptor represent the molecules involved in the electron transfer process.

Examples of enzymes that fall under this category include:

1. Aldehyde dehydrogenases (EC 1.2.1.3): These enzymes catalyze the oxidation of aldehydes to carboxylic acids, using NAD+ as an electron acceptor.
2. Dihydrodiol dehydrogenase (EC 1.3.1.14): This enzyme is responsible for the oxidation of dihydrodiols to catechols in the biodegradation of aromatic compounds.
3. Succinate dehydrogenase (EC 1.3.5.1): A key enzyme in the citric acid cycle, succinate dehydrogenase catalyzes the oxidation of succinate to fumarate and reduces FAD to FADH2.
4. Xylose reductase (EC 1.1.1.307): This enzyme is involved in the metabolism of pentoses, where it reduces xylose to xylitol using NADPH as a cofactor.

Dihydropteridine reductase is an enzyme that plays a crucial role in the metabolism of certain amino acids, specifically phenylalanine and tyrosine. This enzyme is responsible for reducing dihydropteridines to tetrahydropteridines, which is a necessary step in the regeneration of tetrahydrobiopterin (BH4), an essential cofactor for the enzymes phenylalanine hydroxylase and tyrosine hydroxylase.

Phenylalanine hydroxylase and tyrosine hydroxylase are involved in the conversion of the amino acids phenylalanine and tyrosine to tyrosine and dopa, respectively. Without sufficient BH4, these enzymes cannot function properly, leading to an accumulation of phenylalanine and a decrease in the levels of important neurotransmitters such as dopamine, norepinephrine, and serotonin.

Deficiency in dihydropteridine reductase can lead to a rare genetic disorder known as dihydropteridine reductase deficiency (DPRD), which is characterized by elevated levels of phenylalanine and neurotransmitter imbalances, resulting in neurological symptoms such as developmental delay, seizures, and hypotonia. Treatment typically involves a low-phenylalanine diet and supplementation with BH4.

Thioredoxin Reductase 1 (TXNRD1) is an enzyme that belongs to the thioredoxin reductase family. It is a homodimeric flavoprotein that contains a selenocysteine residue at its active site, which is essential for its catalytic activity.

The primary function of TXNRD1 is to reduce and regenerate the oxidized form of thioredoxin (TXN) by using NADPH as an electron donor. Thioredoxin is a small protein that plays a crucial role in maintaining the redox balance within the cell by regulating various cellular processes, such as DNA synthesis, gene expression, and apoptosis.

TXNRD1 is widely expressed in various tissues and is localized in the cytosol of the cell. It has been implicated in several physiological and pathological processes, including inflammation, oxidative stress, cancer, and neurodegenerative diseases. Inhibition of TXNRD1 has been shown to have potential therapeutic benefits in various disease models, making it an attractive target for drug development.

Oxidation-Reduction (redox) reactions are a type of chemical reaction involving a transfer of electrons between two species. The substance that loses electrons in the reaction is oxidized, and the substance that gains electrons is reduced. Oxidation and reduction always occur together in a redox reaction, hence the term "oxidation-reduction."

In biological systems, redox reactions play a crucial role in many cellular processes, including energy production, metabolism, and signaling. The transfer of electrons in these reactions is often facilitated by specialized molecules called electron carriers, such as nicotinamide adenine dinucleotide (NAD+/NADH) and flavin adenine dinucleotide (FAD/FADH2).

The oxidation state of an element in a compound is a measure of the number of electrons that have been gained or lost relative to its neutral state. In redox reactions, the oxidation state of one or more elements changes as they gain or lose electrons. The substance that is oxidized has a higher oxidation state, while the substance that is reduced has a lower oxidation state.

Overall, oxidation-reduction reactions are fundamental to the functioning of living organisms and are involved in many important biological processes.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Oxidoreductases acting on sulfur group donors are a class of enzymes that catalyze redox reactions involving sulfur group donors. These enzymes play a crucial role in various biological processes, such as the metabolism of sulfur-containing compounds and the detoxification of xenobiotics.

The term "oxidoreductase" refers to any enzyme that catalyzes an oxidation-reduction reaction, where one molecule is oxidized (loses electrons) and another is reduced (gains electrons). In the case of oxidoreductases acting on sulfur group donors, the sulfur atom in the substrate serves as the electron donor.

The systematic name for this class of enzymes follows a specific format: "donor:acceptor oxidoreductase." The donor is the sulfur-containing compound that donates electrons, and the acceptor is the molecule that accepts the electrons. For example, the enzyme that catalyzes the reaction between glutathione (GSH) and a variety of electrophiles is called glutathione transferase, or GST (donor:acceptor oxidoreductase).

These enzymes are further classified into subclasses based on the type of acceptor involved in the reaction. Examples include:

* EC 1.8.1: Oxidoreductases acting on CH-NH2 group donors
* EC 1.8.3: Oxidoreductases acting on CH or CH2 groups
* EC 1.8.4: Oxidoreductases acting on the CH-CH group of donors
* EC 1.8.5: Oxidoreductases acting on a sulfur group of donors
* EC 1.8.6: Oxidoreductases acting on NADH or NADPH

The subclass EC 1.8.5, oxidoreductases acting on a sulfur group of donors, includes enzymes that catalyze redox reactions involving sulfur-containing compounds such as thiols (compounds containing -SH groups), disulfides (-S-S- bonds), and other sulfur-containing functional groups. These enzymes play crucial roles in various biological processes, including detoxification, antioxidant defense, and redox regulation.

Mevalonic acid is not a term that is typically used in medical definitions, but rather it is a biochemical concept. Mevalonic acid is a key intermediate in the biosynthetic pathway for cholesterol and other isoprenoids. It is formed from 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) by the enzyme HMG-CoA reductase, which is the target of cholesterol-lowering drugs known as statins.

In a medical context, mevalonic acid may be mentioned in relation to certain rare genetic disorders, such as mevalonate kinase deficiency (MKD) or hyperimmunoglobulinemia D and periodic fever syndrome (HIDS), which are caused by mutations in the gene encoding mevalonate kinase, an enzyme involved in the metabolism of mevalonic acid. These conditions can cause recurrent fevers, rashes, joint pain, and other symptoms.

Lovastatin is a medication that belongs to a class of drugs called statins, which are used to lower cholesterol levels in the blood. It works by inhibiting HMG-CoA reductase, an enzyme that plays a crucial role in the production of cholesterol in the body. By reducing the amount of cholesterol produced in the liver, lovastatin helps to decrease the levels of low-density lipoprotein (LDL) or "bad" cholesterol and triglycerides in the blood, while increasing the levels of high-density lipoprotein (HDL) or "good" cholesterol.

Lovastatin is available in both immediate-release and extended-release forms, and it is typically taken orally once or twice a day, depending on the dosage prescribed by a healthcare provider. Common side effects of lovastatin include headache, nausea, diarrhea, and muscle pain, although more serious side effects such as liver damage and muscle weakness are possible, particularly at higher doses.

It is important to note that lovastatin should not be taken by individuals with active liver disease or by those who are pregnant or breastfeeding. Additionally, it may interact with certain other medications, so it is essential to inform a healthcare provider of all medications being taken before starting lovastatin therapy.

Arsenate reductases are enzymes that catalyze the reduction of arsenate (As(V)) to arsenite (As(III)). This reaction is a critical step in the detoxification process of arsenic compounds in many organisms, including bacteria, fungi, and plants. The enzyme typically uses thioredoxin or glutaredoxin as an electron donor to reduce arsenate.

The medical significance of arsenate reductases lies in their role in arsenic detoxification and resistance. Exposure to high levels of arsenic can lead to a variety of health issues, including skin lesions, cancer, and neurological disorders. Understanding the mechanisms of arsenate reduction and detoxification may provide insights into new strategies for treating arsenic poisoning and developing environmental remediation technologies.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Dinitrogenase reductase is a protein involved in the process of nitrogen fixation in certain bacteria and archaea. It is responsible for delivering electrons to the enzyme dinitrogenase, which converts atmospheric nitrogen (N2) into ammonia (NH3), making it available for use by living organisms. Dinitrogenase reductase contains a cluster of iron and sulfur atoms that facilitate the transfer of electrons. The combined action of dinitrogenase reductase and dinitrogenase allows these microorganisms to utilize nitrogen from the atmosphere as a source of nitrogen for growth, making them important contributors to the global nitrogen cycle.

Sugar alcohol dehydrogenases (SADHs) are a group of enzymes that catalyze the interconversion between sugar alcohols and sugars, which involves the gain or loss of a pair of electrons, typically in the form of NAD(P)+/NAD(P)H. These enzymes play a crucial role in the metabolism of sugar alcohols, which are commonly found in various plants and some microorganisms.

Sugar alcohols, also known as polyols, are reduced forms of sugars that contain one or more hydroxyl groups instead of aldehyde or ketone groups. Examples of sugar alcohols include sorbitol, mannitol, xylitol, and erythritol. SADHs can interconvert these sugar alcohols to their corresponding sugars through a redox reaction that involves the transfer of hydrogen atoms.

The reaction catalyzed by SADHs is typically represented as follows:

R-CH(OH)-CH2OH + NAD(P)+ ↔ R-CO-CH2OH + NAD(P)H + H+

where R represents a carbon chain, and CH(OH)-CH2OH and CO-CH2OH represent the sugar alcohol and sugar forms, respectively.

SADHs are widely distributed in nature and have been found in various organisms, including bacteria, fungi, plants, and animals. These enzymes have attracted significant interest in biotechnology due to their potential applications in the production of sugar alcohols and other value-added products. Additionally, SADHs have been studied as targets for developing novel antimicrobial agents, as inhibiting these enzymes can disrupt the metabolism of certain pathogens that rely on sugar alcohols for growth and survival.

Flavin-Adenine Dinucleotide (FAD) is a coenzyme that plays a crucial role in various metabolic processes, particularly in the electron transport chain where it functions as an electron carrier in oxidation-reduction reactions. FAD is composed of a flavin moiety, riboflavin or vitamin B2, and adenine dinucleotide. It can exist in two forms: an oxidized form (FAD) and a reduced form (FADH2). The reduction of FAD to FADH2 involves the gain of two electrons and two protons, which is accompanied by a significant conformational change that allows FADH2 to donate its electrons to subsequent components in the electron transport chain, ultimately leading to the production of ATP, the main energy currency of the cell.

Hydrogensulfite reductase is an enzyme found in certain bacteria and archaea that catalyzes the reduction of hydrogen sulfite (bisulfite) to sulfide, using NADPH or NADH as an electron donor. This reaction is a part of the microbial dissimilatory sulfate reduction pathway, where sulfate is reduced to sulfide and ultimately used as an electron sink for energy conservation.

The overall reaction catalyzed by hydrogensulfite reductase can be represented as follows:

HSiO3- (hydrogen sulfite) + 2H+ + 2e- → H2S (sulfide) + H2O

There are two main types of hydrogensulfite reductases, which differ in their cofactor requirements and subunit composition:

1. NADPH-dependent membrane-bound (type I) hydrogensulfite reductase: This enzyme is composed of multiple subunits and contains FAD, iron-sulfur clusters, and siroheme as cofactors. It catalyzes the reduction of hydrogen sulfite to sulfide using NADPH as an electron donor, and it is typically found in bacteria that grow under chemolithotrophic conditions (e.g., utilizing sulfur compounds or hydrogen as energy sources).
2. NADH-dependent cytoplasmic (type II) hydrogensulfite reductase: This enzyme consists of a single subunit and contains siroheme and iron-sulfur clusters as cofactors. It catalyzes the reduction of hydrogen sulfite to sulfide using NADH as an electron donor, and it is commonly found in bacteria that grow under heterotrophic conditions (e.g., utilizing organic compounds as energy sources).

In both cases, hydrogensulfite reductase plays a crucial role in the microbial sulfur cycle, contributing to the transformation of various sulfur species and their incorporation into or release from biomolecules.

Hydroxymethylglutaryl-CoA-Reductases (NADP-dependent) are a group of enzymes that play a crucial role in the metabolic pathway known as cholesterol biosynthesis. The NADP-dependent hydroxymethylglutaryl-CoA reductase (HMGCR) is the rate-limiting enzyme in this pathway, and it catalyzes the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) to mevalonic acid using nicotinamide adenine dinucleotide phosphate (NADPH) as a cofactor.

Mevalonic acid is a key intermediate in the biosynthesis of cholesterol and other isoprenoids, making HMGCR an important target for cholesterol-lowering drugs such as statins. Mutations in the gene encoding HMGCR can lead to several genetic disorders, including megacephaly-capillary malformation syndrome and cerebrotendinous xanthomatosis.

Hydroxypyruvate Reductase is an enzyme involved in the metabolism of carbohydrates. Specifically, it catalyzes the conversion of hydroxypyruvate to glycerate during the photorespiratory cycle in plants and some bacteria. This reaction is a part of the process that recovers carbon from the 2-phosphoglycolate generated by the oxygenase activity of ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) during photosynthesis.

The enzyme Hydroxypyruvate Reductase belongs to the family of oxidoreductases, more specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is hydroxypyruvate:NAD(P)+ 2-oxidoreductase. Other common names include D-glycerate dehydrogenase, serine glyoxalate transaminase, and L-serine transaminase.

Folic acid antagonists are a class of medications that work by inhibiting the action of folic acid or its metabolic pathways. These drugs are commonly used in the treatment of various types of cancer and certain other conditions, such as rheumatoid arthritis. They include drugs such as methotrexate, pemetrexed, and trimetrexate.

Folic acid is a type of B vitamin that is essential for the production of DNA and RNA, the genetic material found in cells. Folic acid antagonists work by interfering with the enzyme responsible for converting folic acid into its active form, tetrahydrofolate. This interference prevents the formation of new DNA and RNA, which is necessary for cell division and growth. As a result, these drugs can inhibit the proliferation of rapidly dividing cells, such as cancer cells.

It's important to note that folic acid antagonists can also affect normal, non-cancerous cells in the body, particularly those that divide quickly, such as cells in the bone marrow and digestive tract. This can lead to side effects such as anemia, mouth sores, and diarrhea. Therefore, these drugs must be used carefully and under the close supervision of a healthcare provider.

Thioredoxins are a group of small proteins that contain a redox-active disulfide bond and play a crucial role in the redox regulation of cellular processes. They function as electron donors and help to maintain the intracellular reducing environment by reducing disulfide bonds in other proteins, thereby regulating their activity. Thioredoxins also have antioxidant properties and protect cells from oxidative stress by scavenging reactive oxygen species (ROS) and repairing oxidatively damaged proteins. They are widely distributed in various organisms, including bacteria, plants, and animals, and are involved in many physiological processes such as DNA synthesis, protein folding, and apoptosis.

Thioredoxin Reductase 2 (Txnrd2) is an antioxidant enzyme that plays a crucial role in maintaining the redox balance within cells, particularly in the mitochondria. It is a member of the thioredoxin reductase family, which are selenium-containing proteins that catalyze the reduction of various substrates through the use of NADPH as an electron donor.

Txnrd2 specifically reduces the disulfide bond in mitochondrial thioredoxin 2 (Trx2), regenerating its active form and allowing it to neutralize reactive oxygen species (ROS) and maintain the redox state of proteins within the mitochondria. This enzyme is essential for protecting cells against oxidative stress, which can damage cellular components such as DNA, proteins, and lipids. Dysregulation of Txnrd2 has been implicated in various pathological conditions, including neurodegenerative diseases, cancer, and aging.

Pyrroline-5-carboxylate reductase (PCR) is an enzyme that belongs to the family of oxidoreductases. Specifically, it is a part of the subclass of aldo-keto reductases. This enzyme catalyzes the chemical reaction that converts pyrroline-5-carboxylate to proline, which is an essential step in the biosynthesis of proline, an important proteinogenic amino acid.

The reaction catalyzed by PCR involves the reduction of a keto group to a hydroxyl group, and it requires the cofactor NADPH as a reducing agent. The systematic name for this enzyme is pyrroline-5-carboxylate:NADP+ oxidoreductase (proline-forming).

Deficiencies in PCR have been associated with several human diseases, including hyperprolinemia type II, a rare inherited disorder characterized by an accumulation of pyrroline-5-carboxylate and proline in body fluids.

Dicarbonyl/L-xylulose reductase, also known as carbonyl reductase II, is an enzyme that in human is encoded by the DCXR gene ... L-xylulose+reductase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology v t e (Articles ... Cho-Vega JH, Tsavachidis S, Do KA, Nakagawa J, Medeiros LJ, McDonnell TJ (2007). "Dicarbonyl/L-xylulose reductase: a potential ... In enzymology, an L-xylulose reductase (EC 1.1.1.10) is an enzyme that catalyzes the chemical reaction xylitol + NADP+ ⇌ {\ ...
In enzymology, a D-xylulose reductase (EC 1.1.1.9) is an enzyme that catalyzes the chemical reaction xylitol + NAD+ ⇌ {\ ... The systematic name of this enzyme class is xylitol:NAD+ 2-oxidoreductase (D-xylulose-forming). Other names in common use ... Hickman J; Ashwell G (1959). "A sensitive and stereospecific enzymatic assay for xylulose". J. Biol. Chem. 234: 758-761. PMID ... displaystyle \rightleftharpoons } D-xylulose + NADH + H+ Thus, the two substrates of this enzyme are xylitol and NAD+, whereas ...
It is associated with a deficiency of L-xylulose reductase, necessary for xylitol metabolism. L-Xylulose is a reducing sugar, ... L-xylulose reductase, contained in red blood cells, is composed of both a major and minor isozyme. For those diagnosed with ... Lane, A.B. (February 1984). "On the Nature of L-Xylulose Reductase Deficiency in Essential Pentosuria". Biochemical Genetics. ...
D-xylulose is then phosphorylated to D-xylulose-5-phosphate as in the oxido-reductase pathway. At equilibrium, the isomerase ... Xylitol is then oxidized to D-xylulose by XDH, using the cofactor NAD. In the last step D-xylulose is phosphorylated by an ATP ... This pathway is also called the "Xylose Reductase-Xylitol Dehydrogenase" or XR-XDH pathway. Xylose reductase (XR) and xylitol ... D-xylulose because the conversion of xylose to xylulose is energetically unfavorable. The Weimberg pathway is an oxidative ...
L-Xylulose accumulates in the urine in patients with pentosuria, due to a deficiency in L-xylulose reductase. Since L-xylulose ... Xylulose is a ketopentose, a monosaccharide containing five carbon atoms, and including a ketone functional group. It has the ... Data is for L-xylulose. Merck Index, 11th Edition, 9996. Winkelhausen, Eleonora; Kuzmanova, Slobodanka (1998). "Microbial ...
Food portal Medicine portal Aspartame Birch sap L-Xylulose reductase Xylonic acid Safety data sheet for xylitol Archived 3 ... which transforms xylitol to D-xylulose. Specific xylulokinase phosphorylates it to D-xylulose-5-phosphate. This then goes to ...
The concerted action of these enzymes converts xylose to xylulose, which is naturally fermented by S. cerevisiae. Additional ... coding for xylose reductase and xylitol dehydrogenase, respectively. ...
EC 1.1.1.8 D-xylulose reductase EC 1.1.1.9 L-xylulose reductase EC 1.1.1.10 Lactate dehydrogenase EC 1.1.1.27 Malate ... reductase EC 1.17.4.1 Ribonucleoside-triphosphate reductase EC 1.17.4.2 Vitamin K epoxide reductase Vitamin-K-epoxide reductase ... Nitrite reductase EC 1.7.99.3 Nitrate reductase EC 1.7.99.4 Category:EC 1.8.1 (with NAD+ or NADP+ as acceptor) Glutathione ... Dihydrofolate reductase EC 1.5.1.3 Methylenetetrahydrofolate reductase EC 1.5.1.20 Category:EC 1.5.3 (with oxygen as acceptor) ...
... aldehyde reductase MeSH D08.811.682.047.150.700.237 - d-xylulose reductase MeSH D08.811.682.047.150.700.400 - glycerolphosphate ... gmp reductase MeSH D08.811.682.655.500 - nitrate reductases MeSH D08.811.682.655.500.124 - nitrate reductase MeSH D08.811. ... nitrite reductases MeSH D08.811.682.655.750.249 - ferredoxin-nitrite reductase MeSH D08.811.682.655.750.500 - nitrite reductase ... testosterone 5-alpha-Reductase MeSH D08.811.682.662.162 - dihydropteridine reductase MeSH D08.811.682.662.171 - FMN reductase ...
... butenyl-4-diphosphate reductase (HDR). The formation of IPP can be achieved by both MVA and MEP pathways. Condensation of IPP ... to produce 1-deoxy-D-xylulose-5-phosphate (DXP). The conversion of DXP to isopentenyl diphosphate (IPP), which is the common ... synthesis begins with condensation reaction between pyruvate and D-Glyceraldehyde-3-phosphate catalyzed by 1-deoxy-D-xylulose-5 ... terpenoid biosynthesis precursor involves 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) and 1-hydroxy-2-methyl-2(E)- ...
D-xylulose reductase EC 1.1.1.10: L-xylulose reductase EC 1.1.1.11: D-arabinitol 4-dehydrogenase EC 1.1.1.12: L-arabinitol 4- ... flavin reductase (NADH) EC 1.5.1.37: FAD reductase (NADH) EC 1.5.1.38: FMN reductase (NADPH) EC 1.5.1.39: FMN reductase (NAD(P) ... zeatin reductase EC 1.3.1.70: Δ14-sterol reductase EC 1.3.1.71: Δ24(241)-sterol reductase EC 1.3.1.72: Δ24-sterol reductase EC ... nitrite reductase (NAD(P)H) EC 1.7.1.5: hyponitrite reductase EC 1.7.1.6: azobenzene reductase EC 1.7.1.7: GMP reductase EC 1.7 ...
The classical mevalonate pathway (MVA pathway or HMG-CoA reductase pathway) is a metabolic pathway for the biosynthesis of ... Lichtenthaler H (1999). "The 1-Deoxy-D-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants". Annu Rev Plant ... pathway-also appearing as the mevalonate-independent pathway and the 2-C-methyl-D-erythritol 4-phosphate/1-deoxy-D-xylulose 5- ...
In the kidney, MIOX converts myo-inositol to glucuronic acid which is then able to enter the glucuronate-xylulose pathway for ... the MIOX protein fold diverges from that of other non-heme di-iron oxygenases including ribonucleotide reductase and soluble ... the predominant role of the glucuronate-xylulose-pentose phosphate pathway". Annals of the New York Academy of Sciences. 165 (2 ... conversion to xylulose-5-phosphate. This product can then easily enter the pentose phosphate pathway. Hence, MIOX enables the ...
It reduces glutathione via glutathione reductase, which converts reactive H2O2 into H2O by glutathione peroxidase. If absent, ... 2 xylulose-5-phosphate → 2 fructose-6-phosphate + glyceraldehyde-3-phosphate Glucose-6-phosphate dehydrogenase is the rate- ...
HMBDP is reduced to IPP in the presence of ferredoxin and NADPH by the enzyme HMBDP reductase. The last two steps involving ... Glyceraldehyde 3-phosphate and pyruvate, intermediates of photosynthesis, are converted to deoxy-D-xylulose 5-phosphate (DXP) ... HMBPD synthase and reductase can only occur in completely anaerobic environments. IPP is then able to isomerize to DMAPP via ...
... hydroxymethylglutaryl-CoA reductase (NADPH)] kinase EC 2.7.1.110: Now EC 2.7.11.3, dephospho-(reductase kinase) kinase EC 2.7. ... 1-deoxy-D-xylulose-5-phosphate synthase EC 2.2.1.8: fluorothreonine transaldolase EC 2.2.1.9: 2-succinyl-5-enolpyruvyl-6- ... glutamyl-tRNA reductase and EC 5.4.3.8 glutamate-1-semialdehyde 2,1-aminomutase EC 2.7.2.14: branched-chain-fatty-acid kinase ... dinitrogen-reductase ADP-D-ribosyltransferase EC 2.4.2.38: glycoprotein 2-β-D-xylosyltransferase EC 2.4.2.39: xyloglucan 6- ...
... catalyzed by sulfolactaldehyde reductase and using NADH as a co-factor). Expression of proteins within the sulfo-EMP operon of ... yielding xylulose-5-phosphate (Xu5P). 4-Sulfoerythrose is isomerized to 4-sulfoerythrulose (SEu), whereupon a second round of ... catalyzed by sulfolactaldehyde reductase and using NADH as a co-factor), or oxidized to sulfolactate (catalyzed by ... yielding a second molecule of xylulose-5-phosphate (Xu5P). Finally, the sulfoacetaldehyde is reduced to isethionate and ...
Since NADPH is required by both thioredoxin reductase and glutathione reductase to reduce oxidized thioredoxin and ... Isolation of beta-keto-L-gluconic acid, an intermediate in L-xylulose biosynthesis". J. Biol. Chem. 236: 2975-2980. Scott DBM; ...
This was accomplished via overexpressing heterologous xylulose kinase and endogenous xylose isomerase. A European patent has ... "Cloning of the pks3 gene of Aurantiochytrium limacinum and functional study of the 3-ketoacyl-ACP reductase and dehydratase ...
The mevalonate pathway (also called HMG-CoA reductase pathway) begins with acetyl-CoA and ends with dimethylallyl diphosphate ( ... Lichtenthaler HK (June 1999). "The 1-deoxy-d-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants". Annual Review ... 5α-Reductase and 3α-Hydroxysteroid dehydrogenase. Steroids are primarily oxidized by cytochrome P450 oxidase enzymes, such as ...
This reduced form of the coenzyme is then a substrate for any of the reductases in the cell that need to transfer hydrogen ... Lichtenthaler HK (June 1999). "The 1-Deoxy-D-Xylulose-5-Phosphate Pathway of Isoprenoid Biosynthesis in Plants". Annual Review ...
Dicarbonyl/L-xylulose reductase, also known as carbonyl reductase II, is an enzyme that in human is encoded by the DCXR gene ... L-xylulose+reductase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology v t e (Articles ... Cho-Vega JH, Tsavachidis S, Do KA, Nakagawa J, Medeiros LJ, McDonnell TJ (2007). "Dicarbonyl/L-xylulose reductase: a potential ... In enzymology, an L-xylulose reductase (EC 1.1.1.10) is an enzyme that catalyzes the chemical reaction xylitol + NADP+ ⇌ {\ ...
... is a highly conserved and phylogenetically widespread enzyme converting L-xylulose into xylitol. It also reduces highly ... Dicarbonyl/L-xylulose reductase (DCXR) is a highly conserved and phylogenetically widespread enzyme converting L-xylulose into ... Dicarbonyl/l-xylulose reductase (DCXR): The multifunctional pentosuria enzyme Sun-Kyung Lee 1 , Le Tho Son, Hee-Jung Choi, ... Dicarbonyl/l-xylulose reductase (DCXR): The multifunctional pentosuria enzyme Sun-Kyung Lee et al. Int J Biochem Cell Biol. ...
Recombinant Human L-Xylulose Reductase is produced by our E.coli expression system and the target gene encoding Met1-Cys244 is ...
Essential pentosuria is a condition characterized by high levels of a sugar called L-xylulose in urine. Explore symptoms, ... Lee SK, Son le T, Choi HJ, Ahnn J. Dicarbonyl/l-xylulose reductase (DCXR): The multifunctional pentosuria enzyme. Int J Biochem ... On the nature of L-xylulose reductase deficiency in essential pentosuria. Biochem Genet. 1985 Feb;23(1-2):61-72. doi: 10.1007/ ... This gene provides instructions for making a protein called dicarbonyl and L-xylulose reductase (DCXR), which plays multiple ...
DCXR: dicarbonyl and L-xylulose reductase. *DDC: dopa decarboxylase. *DDX11: DEAD/H-box helicase 11 ...
Diacetyl/l-Xylulose Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells. Chem Res Toxicol. 2017 Jul 17;30(7): ... Measuring nitrate reductase activity from human and rodent tongues. Nitric Oxide. 2017 Jun 1;66:62-70. doi: 10.1016/j.niox. ... Efficient Reduction of Vertebrate Cytoglobins by the Cytochrome b5/Cytochrome b5 Reductase/NADH System. Biochemistry. 2017 Aug ...
L-xylulose reductase. -. 1.1.1.100. 3-oxoacyl-[acyl-carrier-protein] reductase. -. 1.1.1.101. acylglycerone-phosphate reductase ...
Diacetyl/l-Xylulose Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells. Yang, Shaojun; Jan, Yi-Hua; Mishin, ... Sepiapterin reductase mediates chemical redox cycling in lung epithelial cells. Yang, Shaojun; Jan, Yi-Hua; Gray, Joshua P; ... Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity. Wang, Yun; Gray, Joshua P; Mishin, ... Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl eth ... Gray, Joshua P; Mishin ...
6. L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.. Matsunaga T; ... 3. Aldo-keto reductase 1C15 as a quinone reductase in rat endothelial cell: its involvement in redox cycling of 9,10- ... 8. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human ... 9,10-Phenanthrenequinone promotes secretion of pulmonary aldo-keto reductases with surfactant.. Matsunaga T; Haga M; Watanabe G ...
Diacetyl/l-Xylulose Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells. Chem Res Toxicol. 2017 Jul 17;30(7): ... Measuring nitrate reductase activity from human and rodent tongues. Nitric Oxide. 2017 Jun 1;66:62-70. doi: 10.1016/j.niox. ... Efficient Reduction of Vertebrate Cytoglobins by the Cytochrome b5/Cytochrome b5 Reductase/NADH System. Biochemistry. 2017 Aug ...
D27.505.954.329.30.500 D-Xylulose Reductase D8.811.682.47.820.800 Dementia, Vascular C10.228.518.500 Demyelinating Autoimmune ... E2.831.200 Cortisone Reductase D8.811.682.47.436.400.150 D8.811.682.47.820.125.150 Coxa Valga C5.550.338 Coxa Vara C5.550.353 ... C25.775.100.250 Aldehyde Reductase D8.811.682.47.820.275 Alexander Disease C10.228.518.625.312 alpha-2-Antiplasmin D12.776. ... K1.559.411.768 Progesterone Reductase D8.811.682.47.820.500 Propranolol D2.33.100.624.836 D2.33.755.624.836 Psychoses, ...
D Xylulose Reductase use D-Xylulose Reductase D&C use Dilatation and Curettage ...
D-xylulose reductase Current Synonym true false 90788015 D-Xylulose reductase Current Synonym true false ... D-xylulose reductase (substance). Code System Preferred Concept Name. D-xylulose reductase (substance). ...
xylitol NAD 2-oxidoreductase (D-xylulose-forming). Public MeSH Note. 2006; D-XYLULOSE REDUCTASE was indexed under SUGAR ALCOHOL ... D-Xylulose Reductase Preferred Concept UI. M0080441. Registry Number. EC 1.1.1.9. Scope Note. An enzyme that plays a role in ... D-Xylulose Reductase Preferred Term Term UI T110444. LexicalTag NON. ThesaurusID NLM (2006). ... D-Xylulose Reductase. Tree Number(s). D08.811.682.047.150.700.237. D08.811.682.047.820.800. Unique ID. D050542. RDF Unique ...
xylitol NAD 2-oxidoreductase (D-xylulose-forming). Public MeSH Note. 2006; D-XYLULOSE REDUCTASE was indexed under SUGAR ALCOHOL ... D-Xylulose Reductase Preferred Concept UI. M0080441. Registry Number. EC 1.1.1.9. Scope Note. An enzyme that plays a role in ... D-Xylulose Reductase Preferred Term Term UI T110444. LexicalTag NON. ThesaurusID NLM (2006). ... D-Xylulose Reductase. Tree Number(s). D08.811.682.047.150.700.237. D08.811.682.047.820.800. Unique ID. D050542. RDF Unique ...
The protein encoded by this gene acts as a homotetramer to catalyze diacetyl reductase and L-xylulose reductase reactions. The ... alpha-dicarbonyl compounds and L-xylulose. Participates in the uronate cycle of glucose metabolism. May play a role in the ... The protein encoded by this gene acts as a homotetramer to catalyze diacetyl reductase and L-xylulose reductase reactions. The ... Catalyzes the NADPH-dependent reduction of several pentoses, tetroses, trioses, alpha-dicarbonyl compounds and L-xylulose. ...
D Xylulose Reductase use D-Xylulose Reductase D&C use Dilatation and Curettage ...
An exception was the putative L-xylulose reductase encoding gene that had reduced expression levels in compost and casing ... which ends at D-xylulose-5-phosphate, an intermediate of the pentose phosphate pathway (PPP). D-Glucose can enter several ...
D-xylulose reductase activity GO:0046526 * sepiapterin reductase activity GO:0004757 * isopiperitenol dehydrogenase activity ...
Lee SK, Son le T, Choi HJ, Ahnn J. Dicarbonyl/l-xylulose reductase (DCXR): Themultifunctional pentosuria enzyme. Int J Biochem ... This gene provides instructions for making a protein called dicarbonyl and L-xylulose reductase (DCXR), which plays multiple ... On the nature of L-xylulose reductase deficiency in essentialpentosuria. Biochem Genet. 1985 Feb;23(1-2):61-72. ... Molecularcharacterization of mammalian dicarbonyl/L-xylulose reductase and itslocalization in kidney. J Biol Chem. 2002 May 17; ...
dicarbonyl/L-xylulose reductase 30273 766 Yes 17q25.3 dicarbonyl/L-xylulose reductase ...
L-Xylulose reductase deficiency - See Pentosuria. *L-Xylulosuria - See Pentosuria. *LYH - See Lymphocytic hypophysitis ...
Dicarbonyl/l-xylulose reductase (DCXR) metabolizes diacetyl into acetoin, which lacks this alpha-dicarbonyl group. To ...
N0000167841 D-Amino-Acid Oxidase N0000167827 D-Aspartate Oxidase N0000170285 D-Aspartic Acid N0000167972 D-Xylulose Reductase ... N0000169057 Nitrate Reductase (NADH) N0000169643 Nitrate Reductase (NADPH) N0000167939 Nitrate Reductases N0000007647 Nitrates ... h N0000178702 Thioredoxin Reductase 1 N0000178714 Thioredoxin Reductase 2 N0000169063 Thioredoxin-Disulfide Reductase ... Reductase (NADPH, B-Specific) N0000167924 Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) N0000168032 Enoyl-CoA Hydratase ...
D-xylulose reductase (EC 1.1.1.9) (characterized). 31%. 99%. 112.8. 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100). ... D-xylulose reductase (EC 1.1.1.9) (characterized). 31%. 100%. 117.5. 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30). 51%. 276.2 ... D-xylulose reductase (EC 1.1.1.9) (characterized). 32%. 95%. 102.8. alcohol dehydrogenase (EC 1.1.1.1); all-trans-retinol ... Ignore hits to items matching xylulose reductase when looking for other hits ...
D-xylulose reductase (EC 1.1.1.9) (characterized). 33%. 99%. 127.1. A-factor type γ-butyrolactone 6-reductase (6R-forming). 45% ... D-xylulose reductase (EC 1.1.1.9) (characterized). 35%. 100%. 125.2. 2-keto-3-deoxy-L-fuconate dehydrogenase; EC 1.1.1.-. 71%. ... D-xylulose reductase (EC 1.1.1.9) (characterized). 30%. 80%. 99.4. Alcohol dehydrogenase (EC 1.1.1.1). 76%. 546.2. ... Ignore hits to items matching xylulose reductase when looking for other hits ...
  • Dicarbonyl/L-xylulose reductase, also known as carbonyl reductase II, is an enzyme that in human is encoded by the DCXR gene located on chromosome 17. (wikipedia.org)
  • Dicarbonyl/L-xylulose reductase (DCXR) is a highly conserved and phylogenetically widespread enzyme converting L-xylulose into xylitol. (nih.gov)
  • This gene provides instructions for making a protein called dicarbonyl and L-xylulose reductase (DCXR), which plays multiple roles in the body. (medlineplus.gov)
  • Lee SK, Son le T, Choi HJ, Ahnn J. Dicarbonyl/l-xylulose reductase (DCXR): The multifunctional pentosuria enzyme. (medlineplus.gov)
  • Y4LA_RHISN (Uncharacterized short-chain type dehydrogenase/reductase y4lA OS=Rhizobium sp. (citrusgenomedb.org)
  • The oleaginous yeast, Y. lipolytica, is most likely to have a xylose reductase (XYR), xylitol dehydrogenase (XDH), and xylulose kinase (XKS). (biomedcentral.com)
  • In enzymology, an L-xylulose reductase (EC 1.1.1.10) is an enzyme that catalyzes the chemical reaction xylitol + NADP+ ⇌ {\displaystyle \rightleftharpoons } L-xylulose + NADPH + H+ Thus, the two substrates of this enzyme are xylitol and NADP+, whereas its 3 products are L-xylulose, NADPH, and H+. (wikipedia.org)
  • Xylulose Xylitol (Note conversion of ketone to alcohol) This enzyme belongs to the superfamily of short-chain oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. (wikipedia.org)
  • The systematic name of this enzyme class is xylitol:NADP+ 2-oxidoreductase (L-xylulose-forming). (wikipedia.org)
  • One of its functions is to perform a chemical reaction that converts a sugar called L-xylulose to a molecule called xylitol. (medlineplus.gov)
  • Without this protein, L-xylulose is not converted to xylitol, and the excess sugar is released in the urine. (medlineplus.gov)
  • An enzyme that plays a role in the PENTOSES and GLUCURONATES interconversion pathway by catalyzing the oxidation of XYLITOL to D-xylulose. (nih.gov)
  • Through expression of the heterogeneous xylose able source for fuel ethanol production without affecting metabolic pathway-either xylose reductase-xylitol dehy- the food and feed markets. (sagepub.com)
  • The protein encoded by this gene acts as a homotetramer to catalyze diacetyl reductase and L-xylulose reductase reactions. (nih.gov)
  • protein_coding" "Cz05g23010.t1","No alias","Chromochloris zofingiensis","4-hydroxy-3-methylbut-2-enyl diphosphate reductase [Interproscan]. (ntu.edu.sg)
  • There was also a decrease in the abundance of proteins associated with transcription (40 S ribosomal protein S30 (−26 fold), 40 S ribosomal protein S21 (−3 fold) and carbohydrate metabolism (l-xylulose reductase (−10 fold). (teagasc.ie)
  • Probable gamma-glutamyl phosphate reductase protein ProA. (ntu.edu.sg)
  • The previously reported yeast strain BP10001, which expresses heterologous xylose reductase from Candida tenuis in mutated (NADH-preferring) form, stands for a series of other yeast strains designed with similar rational. (tugraz.at)
  • We also carried out a comprehensive investigation on the currently unclear role of coenzyme utilization, NADPH compared to NADH, for xylose reduction during co-fermentation of glucose and xylose.RESULTS:BP10001 and BP000, expressing C. tenuis xylose reductase in NADPH-preferring wild-type form, were used. (tugraz.at)
  • Essential pentosuria is a condition characterized by high levels of a sugar called L-xylulose in urine. (medlineplus.gov)
  • While essential pentosuria is caused by genetic mutations, some people develop a non-inherited form of pentosuria if they eat excessive amounts of fruits high in L-xylulose or another pentose called L-arabinose. (medlineplus.gov)
  • On the nature of L-xylulose reductase deficiency in essential pentosuria. (medlineplus.gov)
  • This enzyme forms a system with a ferredoxin or a flavodoxin and an NAD(P)H-dependent reductase. (qmul.ac.uk)
  • The enzyme acts in the reverse direction, producing a 5:1 mixture of 3-methylbut-3-en-1-yl diphosphate and prenyl diphosphate. (qmul.ac.uk)
  • Catalyzes the NADPH-dependent reduction of several pentoses, tetroses, trioses, alpha-dicarbonyl compounds and L-xylulose. (nih.gov)
  • Engineering of Recombinant Poplar Deoxy-D-Xylulose-5-Phosphate Synthase (PtDXS) by Site-Directed Mutagenesis Improves Its Activity. (cmdm.tw)
  • 3. Aldo-keto reductase 1C15 as a quinone reductase in rat endothelial cell: its involvement in redox cycling of 9,10-phenanthrenequinone. (nih.gov)
  • It is of economic interest to drogenase (XR-XDH) or xylose isomerase (XI)-S. cer- convert all lignocellulosic sugar fractions, predominantly evisiae can convert xylose to xylulose, which can then glucose and xylose, into ethanol at sufficiently high rates be natively catabolized (Matsushika et al. (sagepub.com)
  • The condition is so named because L-xylulose is a type of sugar called a pentose. (medlineplus.gov)
  • Recombinant Human L-Xylulose Reductase is produced by our E.coli expression system and the target gene encoding Met1-Cys244 is expressed with a 6His tag at the N-terminus. (bonopusbio.com)
  • This pathway, also known as the 1-deoxy- D -xylulose 5-phosphate (DOXP) or as the 2- C -methyl- D -erythritol-4-phosphate (MEP) pathway, is found in most bacteria and in plant chloroplasts. (qmul.ac.uk)
  • The insufficiency of L-xylulose reductase activity causes an inborn error of metabolism disease characterized by excessive urinary excretion of L-xylulose. (wikipedia.org)
  • 15. 9,10-phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3. (nih.gov)
  • 6. L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells. (nih.gov)
  • 8. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells. (nih.gov)